XRAY financial statements and SEC filings

XRAY annual income statement

Fiscal period endRevenueOperating incomeNet incomeSEC filing
2025-12-31$3.68B-$422.00M-$598.00M10-K
2024-12-31$3.79B-$879.00M-$910.00M10-K
2023-12-31$3.96B-$85.00M-$132.00M10-K
2022-12-31$3.92B-$937.00M-$950.00M10-K
2021-12-31$4.23B$608.00M$411.00M10-K
2020-12-31$3.34B-$3.00M-$73.00M10-K/A

XRAY annual balance sheet

Fiscal period endAssetsLiabilitiesEquitySEC filing
2025-12-31$5.43B$4.09B$1.34B10-Q
2024-12-31$5.75B$3.81B$1.94B10-K
2023-12-31$7.37B$4.08B$3.29B10-K
2022-12-31$7.64B$3.83B$3.81B10-K
2021-12-31$9.24B$4.24B$5.00B10-K/A
2020-12-31$9.35B$4.42B$4.93B10-K/A

XRAY annual cash flow

Fiscal period endOperating cash flowCapital expenditureFinancing cash flowSEC filing
2025-12-31$235.00M-$131.00M-$80.00M10-K
2024-12-31$461.00M-$180.00M-$302.00M10-K
2023-12-31$377.00M-$149.00M-$307.00M10-K
2022-12-31$517.00M-$149.00M-$329.00M10-K
2021-12-31$657.00M-$142.00M-$379.00M10-K
2020-12-31$649.00M-$87.00M$476.00M10-K/A